Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 3
2007 1
2009 3
2010 2
2011 1
2012 2
2013 1
2014 1
2015 2
2016 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for rogachev va[au]
Your search for Bogachev VA[au] retrieved no results
Identification of cancer stem cells and a strategy for their elimination.
Dolgova EV, Alyamkina EA, Efremov YR, Nikolin VP, Popova NA, Tyrinova TV, Kozel AV, Minkevich AM, Andrushkevich OM, Zavyalov EL, Romaschenko AV, Bayborodin SI, Taranov OS, Omigov VV, Shevela EY, Stupak VV, Mishinov SV, Rogachev VA, Proskurina AS, Mayorov VI, Shurdov MA, Ostanin AA, Chernykh ER, Bogachev SS. Dolgova EV, et al. Among authors: rogachev va. Cancer Biol Ther. 2014 Oct;15(10):1378-94. doi: 10.4161/cbt.29854. Cancer Biol Ther. 2014. PMID: 25117082 Free PMC article.
Combination of cyclophosphamide and double-stranded DNA demonstrates synergistic toxicity against established xenografts.
Alyamkina EA, Nikolin VP, Popova NA, Minkevich AM, Kozel AV, Dolgova EV, Efremov YR, Bayborodin SI, Andrushkevich OM, Taranov OS, Omigov VV, Rogachev VA, Proskurina AS, Vereschagin EI, Kiseleva EV, Zhukova MV, Ostanin AA, Chernykh ER, Bogachev SS, Shurdov MA. Alyamkina EA, et al. Among authors: rogachev va. Cancer Cell Int. 2015 Mar 19;15:32. doi: 10.1186/s12935-015-0180-6. eCollection 2015. Cancer Cell Int. 2015. PMID: 25798073 Free PMC article.
Effect of double-stranded DNA on maturation of dendritic cells in vitro.
Alyamkina EA, Leplina OY, Sakhno LV, Chernykh ER, Ostanin AA, Efremov YR, Shilov AG, Proskurina AS, Orishchenko KE, Dolgova EV, Rogachev VA, Nikolin VP, Popova NA, Zagrebelniy SN, Bogachev SS, Shurdov MA. Alyamkina EA, et al. Among authors: rogachev va. Cell Immunol. 2010;266(1):46-51. doi: 10.1016/j.cellimm.2010.08.011. Epub 2010 Sep 21. Cell Immunol. 2010. PMID: 20863487
Exogenous allogenic fragmented double-stranded DNA is internalized into human dendritic cells and enhances their allostimulatory activity.
Alyamkina EA, Dolgova EV, Likhacheva AS, Rogachev VA, Sebeleva TE, Nikolin VP, Popova NA, Kiseleva EV, Orishchenko KE, Sakhno LV, Gel'fgat EL, Ostanin AA, Chernykh ER, Zagrebelniy SN, Bogachev SS, Shurdov MA. Alyamkina EA, et al. Among authors: rogachev va. Cell Immunol. 2010;262(2):120-6. doi: 10.1016/j.cellimm.2010.01.005. Epub 2010 Feb 1. Cell Immunol. 2010. PMID: 20170907
Effects of human exogenous DNA on production of perforin-containing CD8+ cytotoxic lymphocytes in laboratory setting and clinical practice.
Alyamkina EA, Leplina OY, Ostanin AA, Chernykh ER, Nikolin VP, Popova NA, Proskurina AS, Gvozdeva TS, Dolgova EV, Orishchenko KE, Rogachev VA, Sidorov SV, Varaksin NA, Ryabicheva TG, Bogachev SS, Shurdov MA. Alyamkina EA, et al. Among authors: rogachev va. Cell Immunol. 2012 Mar-Apr;276(1-2):59-66. doi: 10.1016/j.cellimm.2012.04.004. Epub 2012 Apr 7. Cell Immunol. 2012. PMID: 22578800
Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen.
Proskurina AS, Gvozdeva TS, Potter EA, Dolgova EV, Orishchenko KE, Nikolin VP, Popova NA, Sidorov SV, Chernykh ER, Ostanin AA, Leplina OY, Dvornichenko VV, Ponomarenko DM, Soldatova GS, Varaksin NA, Ryabicheva TG, Uchakin PN, Rogachev VA, Shurdov MA, Bogachev SS. Proskurina AS, et al. Among authors: rogachev va. BMC Cancer. 2016 Aug 18;16:651. doi: 10.1186/s12885-016-2711-5. BMC Cancer. 2016. PMID: 27538465 Free PMC article. Clinical Trial.
"Delayed death" phenomenon: a synergistic action of cyclophosphamide and exogenous DNA.
Dolgova EV, Proskurina AS, Nikolin VP, Popova NA, Alyamkina EA, Orishchenko KE, Rogachev VA, Efremov YR, Dubatolova TD, Prokopenko AV, Chernykh ER, Ostanin AA, Taranov OS, Omigov VV, Zagrebelniy SN, Bogachev SS, Shurdov MA. Dolgova EV, et al. Among authors: rogachev va. Gene. 2012 Mar 10;495(2):134-45. doi: 10.1016/j.gene.2011.12.032. Epub 2011 Dec 27. Gene. 2012. PMID: 22227496
Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.
Proskurina AS, Gvozdeva TS, Alyamkina EA, Dolgova EV, Orishchenko KE, Nikolin VP, Popova NA, Sidorov SV, Chernykh ER, Ostanin AA, Leplina OY, Dvornichenko VV, Ponomarenko DM, Soldatova GS, Varaksin NA, Ryabicheva TG, Uchakin PN, Zagrebelniy SN, Rogachev VA, Bogachev SS, Shurdov MA. Proskurina AS, et al. Among authors: rogachev va. BMC Cancer. 2015 Mar 13;15:122. doi: 10.1186/s12885-015-1142-z. BMC Cancer. 2015. PMID: 25886605 Free PMC article. Clinical Trial.
Delivery and processing of exogenous double-stranded DNA in mouse CD34+ hematopoietic progenitor cells and their cell cycle changes upon combined treatment with cyclophosphamide and double-stranded DNA.
Dolgova EV, Efremov YR, Orishchenko KE, Andrushkevich OM, Alyamkina EA, Proskurina AS, Bayborodin SI, Nikolin VP, Popova NA, Chernykh ER, Ostanin AA, Taranov OS, Omigov VV, Minkevich AM, Rogachev VA, Bogachev SS, Shurdov MA. Dolgova EV, et al. Among authors: rogachev va. Gene. 2013 Oct 10;528(2):74-83. doi: 10.1016/j.gene.2013.06.058. Epub 2013 Jul 30. Gene. 2013. PMID: 23911305
Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.
Proskurina AS, Gvozdeva TS, Alyamkina EA, Dolgova EV, Orishchenko KE, Nikolin VP, Popova NA, Sidorov SV, Chernykh ER, Ostanin AA, Leplina OY, Dvornichenko VV, Ponomarenko DM, Soldatova GS, Varaksin NA, Ryabicheva TG, Uchakin PN, Zagrebelniy SN, Rogachev VA, Bogachev SS, Shurdov MA. Proskurina AS, et al. Among authors: rogachev va. BMC Cancer. 2016 Feb 17;16:117. doi: 10.1186/s12885-016-2163-y. BMC Cancer. 2016. PMID: 26887451 Free PMC article. No abstract available.
19 results